project id: TCGA-LUAD; case submitter id: TCGA-67-6217; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 73; days to birth: -26920; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1937; age at diagnosis: 26920; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 422.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: Not Reported; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.7; longest dimension: 1.1; oct embedded: No; shortest dimension: 0.4; portion submitter id: TCGA-67-6217-01A-11; percent necrosis: 0.0; percent stromal cells: 30.0;